Beckymucha, who posts here sometimes, has offered that Cydy
Beckymucha, who posts here sometimes, has offered that Cydy long hauler Miranda was referred to the Cytodyn trial by Dr. Bruce Patterson.
Miranda is one of the three CYDY long haulers who have posted their great CYCY LH trial results. The other two are Eli and Farah.
I think Miranda was the first of the CYDy long haulers to release a video.
Gaylis has said on more than one occassion that the blood lab work, especially cytokines, is essential to success of the CYDY long hauler human trial.
Gaylis has spoken to Patterson about Patterson's work on the Patterson/Yo clinical effort.
I would totally agree that Gaylis only cares about his patients and is only interested in helping them.
Gaylis is a tremndous asset to the leronlimab effort in covid.
Gaylis videos suffer none, as in absolute zero, of the chaos and confusion that is typical of a Cytodyn management communication.
Not only does Gaylis do a much better job producing leronlimab-centric videos, but also Gaylis is bolda and aggressive.
Gaylis efforts in the CYDY long hauler trial may be unprecedented in the history of medicine.
Gaylis is encouraging blinded, placebo-controlled trial patients to publicize their experiences in the CYTY long hauler trial.
Has this ever happened before?
That the principal investigator is facilitating widespread publicity for his patients, WITH EMPHASIS THAT EVERYONE IS STILLE BLINDED, may be unprecedented.
Even more remarkable, during the videos the patients encourage other people who may be suffering long hauler syndrome to contact Dr. Gaylis clinic as soon as possible so they can get lined up for the next trial!
What!?!?!? Blinded, placebo controlled patients are producing promotional videos for the NEXT TRIAL!?!??!
When has that ever happened before?
I wonder if Gaylis asked anyone's permission before he decided to help produce these videos. I suspect NOT.
I wonder if there are any FDA regulations regarding the promotional videos that Gaylis is producing.
Gaylis does not answer to the FDA, he does not answer to CYDY, and he does not answer to big pharma.
I wouldn't be surprised if Gaylis is using Patterson's LH test kit for some of his patients.
If Gaylis is not using Patterson's test kit, its probably because Gaylis decided that the trial sponsored blood work was good enough and he didn't want to alienate CYDY.
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....
Continue Reading
Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...
Continue Reading
Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...
Continue Reading
Introducing the AI Revolution in Film Here we are, folks, standing at the intersection of film and artificial intelligence. China's entertainment behemoth, iQIYI, has just launched what they're touting as the country's first AI Film Studio over in Shanghai. Kicking things off, they've got "Cop in Trouble" queued up, a film that’s promising to leverage the unbridled...
Continue Reading
Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...
Continue Reading
When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...
Continue Reading
Redefining Commerce in the Digital Age Alright, folks, let's chew the fat over something that's flipping the script on digital commerce. Coda, the Southeast Asian powerhouse in digital content monetization, is stirring things up with TikTok Gaming. Since June, it's been cooking up one billion views worth of creative potential from users, tightening the grip on digital...
Continue Reading
What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...
Continue Reading
Top 5 Most Recently Viewed Articles
Data Ramp Unveils Groundbreaking Technology: 1lx Data Ramp, a pioneer in zero-copy data integration, has made headlines with the introduction of 1lx, an innovative technology designed specifically for organizations looking to revolutionize how they handle and enrich customer data. This state-of-the-art solution addresses common data management challenges, allowing...
Continue Reading
Recent Findings on Zigakibart for IgA Nephropathy Recent data from an extended study on zigakibart reveal significant insights into its efficacy and safety as a treatment for IgA nephropathy. Presentations at a notable medical congress highlighted how this investigational monoclonal antibody could transform treatment approaches for this kidney disorder. Understanding IgA...
Continue Reading
Hotel del Coronado's Stunning Transformation and Restoration The legendary Hotel del Coronado has reached an amazing milestone, celebrating the completion of its monumental restoration project valued at over $550 million. This revitalization initiative focuses on preserving the historical significance of the iconic Victorian building while introducing a new era of luxury...
Continue Reading
Exciting Developments in the Tech World The week brought a wave of fascinating news stories from the tech industry, capturing the attention of enthusiasts and investors alike. With significant events like a dispute involving Disney and Google, notable sales achievements for Apple's latest iPhone, and the implications of a major AWS outage, we delve into these key moments....
Continue Reading
Exciting Drilling Progress at Escacena and Cármenes Projects TSXV: PGZ | OTCQB: PGZFF | FRA: 2EU Pan Global Resources Inc. (TSXV: PGZ) is thrilled to share significant advancements regarding its ongoing drill programs at two of its flagship sites, the Escacena Project and the Cármenes Project. These initiatives target high-priority mineralization prospects, including...
Continue Reading